Benin Management Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Sell
23,624
-100
-0.4% -$2.62K 0.12% 85
2026
Q1
$666K Sell
23,724
-800
-3% -$21.3K 0.15% 71
2025
Q4
$611K Buy
24,524
+1,340
+6% +$33.8K 0.14% 77
2025
Q3
$591K Sell
23,184
-500
-2% -$12.3K 0.14% 77
2025
Q2
$574K Buy
23,684
+205
+0.9% +$4.78K 0.15% 79
2025
Q1
$595K Sell
23,479
-2,527
-10% -$66.1K 0.17% 72
2024
Q4
$690K Hold
26,006
0.19% 63
2024
Q3
$753K Sell
26,006
-310
-1% -$9.04K 0.21% 58
2024
Q2
$736K Buy
26,316
+400
+2% +$11K 0.22% 53
2024
Q1
$719K Sell
25,916
-60
-0.2% -$1.67K 0.23% 55
2023
Q4
$748K Sell
25,976
-14,740
-36% -$446K 0.25% 47
2023
Q3
$1.35M Buy
40,716
+2,200
+6% +$77.8K 0.5% 29
2023
Q2
$1.41M Buy
38,516
+1,109
+3% +$43.2K 0.51% 29
2023
Q1
$1.53M Buy
37,407
+1,401
+4% +$60.5K 0.58% 25
2022
Q4
$1.84M Hold
36,006
0.75% 22
2022
Q3
$1.58M Sell
36,006
-100
-0.3% -$4.86K 0.66% 23
2022
Q2
$1.89M Sell
36,106
-1,400
-4% -$71.3K 0.72% 22
2022
Q1
$1.94M Sell
37,506
-747
-2% -$38.8K 0.6% 24
2021
Q4
$2.26M Buy
38,253
+1,701
+5% +$84.3K 0.68% 22
2021
Q3
$1.57M Buy
36,552
+208
+0.6% +$9.21K 0.5% 28
2021
Q2
$1.42M Buy
36,344
+18
+0% +$700 0.45% 31
2021
Q1
$1.32M Buy
36,326
+1,250
+4% +$44.4K 0.47% 31
2020
Q4
$1.29M Buy
35,076
+12,869
+58% +$472K 0.52% 31
2020
Q3
$773K Buy
22,207
+8,074
+57% +$283K 0.35% 39
2020
Q2
$439K Sell
14,133
-264
-2% -$8.97K 0.2% 58
2020
Q1
$446K Sell
14,397
-231
-2% -$7.87K 0.23% 55
2019
Q4
$544K Buy
14,628
+811
+6% +$28.9K 0.23% 57
2019
Q3
$471K Hold
13,817
0.2% 63
2019
Q2
$568K Sell
13,817
-39
-0.3% -$1.55K 0.24% 50
2019
Q1
$558K Sell
13,856
-1,927
-12% -$77.2K 0.24% 50
2018
Q4
$654K Sell
15,783
-1,055
-6% -$43.8K 0.32% 43
2018
Q3
$704K Sell
16,838
-210
-1% -$8.08K 0.28% 49
2018
Q2
$587K Sell
17,048
-422
-2% -$14.4K 0.26% 50
2018
Q1
$588K Hold
17,470
0.26% 48
2017
Q4
$600K Sell
17,470
-1,333
-7% -$45.5K 0.24% 55
2017
Q3
$637K Buy
18,803
+2,337
+14% +$75.1K 0.26% 51
2017
Q2
$525K Buy
16,466
+9
+0.1% +$284 0.23% 56
2017
Q1
$534K Buy
16,457
+1,195
+8% +$37.7K 0.24% 57
2016
Q4
$470K Sell
15,262
-2,996
-16% -$91.5K 0.22% 68
2016
Q3
$587K Sell
18,258
-3,962
-18% -$132K 0.28% 52
2016
Q2
$742K Buy
22,220
+790
+4% +$25.2K 0.38% 48
2016
Q1
$603K Sell
21,430
-738
-3% -$21.1K 0.33% 53
2015
Q4
$679K Sell
22,168
-758
-3% -$23.8K 0.38% 44
2015
Q3
$683K Buy
22,926
+9,311
+68% +$299K 0.37% 46
2015
Q2
$433K Hold
13,615
0.23% 60
2015
Q1
$449K Buy
13,615
+390
+3% +$12.4K 0.24% 60
2014
Q4
$391K Sell
13,225
-115
-0.9% -$3.3K 0.21% 65
2014
Q3
$374K Hold
13,340
0.19% 71
2014
Q2
$376K Buy
13,340
+1,193
+10% +$34K 0.2% 69
2014
Q1
$370K Sell
12,147
-7,467
-38% -$223K 0.23% 67
2013
Q4
$570K Sell
19,614
-421
-2% -$12.3K 0.35% 55
2013
Q3
$546K Sell
20,035
-859
-4% -$23.4K 0.34% 54
2013
Q2
$555K Buy
+20,894
New +$577K 0.34% 52

Other funds holding PFE

Benin Management Corp's PFE Position: Q2 2026 in Review

Benin Management Corp reduced its Pfizer (PFE) stake by 0.42% in Q2 2026, selling an estimated $2.62K and leaving 23,624 shares worth $569K. The position accounts for 0.12% of the portfolio, ranked #85.

Benin Management Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.26M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Benin Management Corp held 23,624 shares of Pfizer worth $569K as of Q2 2026.
  • Benin Management Corp sold 100 Pfizer shares in Q2 2026, an estimated $2.62K.
  • Pfizer made up 0.12% of Benin Management Corp's portfolio in Q2 2026, its #85 holding.
  • Benin Management Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Benin Management Corp's Pfizer position peaked at $2.26M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Benin Management Corp's 13F filing for Q2 2026, filed 15 Jul 2026.